Portal:CPTAC
From WikiPathways
CPTAC Pathways
Welcome to the CPTAC Pathway PortalThis portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC). The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public. The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011. | 
|
Cancer Hallmark Categories
| Sustaining proliferative signaling
MET in type 1 papillary renal cell carcinoma (Homo sapiens) Image does not exist MET in type 1 papillary renal cell carcinoma | Evading growth suppressors
Tumor suppressor activity of SMARCB1 (Homo sapiens) Image does not exist Tumor suppressor activity of SMARCB1 | Activating invasion and metastasis
Neural crest cell migration in cancer (Homo sapiens) Image does not exist Neural crest cell migration in cancer |
| Enabling replicative immortality
Regulation of Wnt / B-catenin signaling by small molecule compounds (Homo sapiens) Image does not exist Regulation of Wnt / B-catenin signaling by small molecule compounds | Inducing angiogenesis
Hedgehog signaling (Homo sapiens) Image does not exist Hedgehog signaling | Resisting cell death
miRNA regulation of p53 pathway in prostate cancer (Homo sapiens) Image does not exist miRNA regulation of p53 pathway in prostate cancer |
| Deregulating cellular energetics
Hereditary leiomyomatosis and renal cell carcinoma pathway (Homo sapiens) Image does not exist Hereditary leiomyomatosis and renal cell carcinoma pathway | Genome instability and mutation
DNA damage response (only ATM dependent) (Homo sapiens) Image does not exist DNA damage response (only ATM dependent) | Tumor promoting inflammation
IL1 signaling (Homo sapiens) Image does not exist IL1 signaling |
| Avoiding immune destruction
Altered glycosylation of MUC1 in tumor microenvironment (Homo sapiens) Image does not exist Altered glycosylation of MUC1 in tumor microenvironment | Therapeutics
Irinotecan pathway (Homo sapiens) Image does not exist Irinotecan pathway |
Featured Pathways
|
Image does not exist PDGFR-beta pathway Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
| View featured pathways |
| List of all pathways for this portal |
Pathway Curation
On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.
Getting Started
- Introduction to WikiPathways (slides)
- WikiPathways Overview or New Contributor Quickstart
- General help pages
- CPTAC Workshop Exercises
Resources
- Learn more about CPTAC
- Pathway analysis
- Cytoscape and the WikiPathways app
- PathVisio and the WikiPathways plugin
Curation projects
- Curating Hallmark Pathways -- How to
- Example: construction of Pathways in Renal Cancer
- Contact Alex Pico if interested in curating, adding or using CPTAC pathways, [email protected]
